Dr. Heller is an experienced leader and mentor in healthcare, spanning multiple life science sectors, including pharma, biotech, non-profit, academic, and organizations from early-stage start-ups to Fortune 500 companies. Early in her career, she led a clinical drug development program in pharma, and most recently launched IBD Ventures and IBD Therapeutics Incubator, venture philanthropy initiatives from the Crohn’s & Colitis Foundation, where she was Chief Scientific Officer. Dr. Heller joined Frezent as an executive management advisor in 2025..